Streetbeat News

Earnings

ANIP

DOV

GOOGL

RCM

Insiders at Alphabet, Dover, ANI Pharmaceuticals, and R1 RCM have recently sold shares. These sales could indicate various sentiments about the companies' prospects or stock valuations. Notably, ANI Pharmaceuticals reported positive earnings, R1 RCM showed disappointing sales, Dover's revenue declined, and Alphabet's new Pixel 8 will lack a key feature.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 12:10 pm

DUO

PIK

SELX

Fangdd Network Group Ltd. (NASDAQ:DUO) shares surged 78.3% in pre-market trading after announcing its 2024 strategic plan to enter the real estate stock asset services sector. Other stocks showed significant movement in pre-market trading, with Kidpik Corp. (NASDAQ:PIK) and Auddia Inc. (NASDAQ:AUUD) among the top gainers, while Semilux International Ltd. (NASDAQ:SELX) and Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) led the losers.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 12:08 pm

LCTX

Lineage Cell Therapeutics, Inc. (LCTX) announced that preclinical results for OpRegen will be presented at the 2024 ARVO meeting. OpRegen, developed in collaboration with Roche and Genentech, is a treatment for geographic atrophy secondary to age-related macular degeneration. The study shows OpRegen's engraftment in the retinal pigmented epithelium of mini-pigs, indicating potential benefits for retinal health and function. The presentation will highlight the survival and distribution of OpRegen post-administration.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:06 pm

Jacobs Solutions Inc (NYSE:J) and Mott MacDonald have been chosen by Thames Water to support the delivery of its $5.9 billion asset investment programs. This eight-year deal involves technical, engineering, and planning services for major water infrastructure projects in the UK. Jacobs recently reported a 9.5% YoY revenue growth and an adjusted EPS of $2.02 for the first quarter of FY24.

Portfolio Pulse from Lekha Gupta

March 11, 2024 | 12:05 pm

LEXO

LEXO shares have experienced an uptick following the announcement of improved Q4 EPS results compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:59 am

LXEO

Lexeo Therapeutics (NASDAQ:LXEO) reported a significant improvement in its Q4 earnings, with a loss of $(0.86) per share compared to a loss of $(8.86) per share year-over-year, marking a 90.29% increase in earnings.

Portfolio Pulse from Happy Mohamed

March 11, 2024 | 11:56 am

BNTX

BioNTech announced it will present clinical data updates for its personalized mRNA-based and targeted oncology candidates at the AACR 2024 conference. This showcases the company's ongoing efforts in advancing its oncology pipeline.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:53 am

AUR

DAVA

LPSN

SMSI

SNOW

The article highlights the top 5 oversold tech stocks in March, based on their RSI values being near or below 30, indicating potential undervaluation. These include Smith Micro Software (SMSI), Aurora Innovation (AUR), Snowflake (SNOW), Endava (DAVA), and LivePerson (LPSN), each with recent financial results and stock performance updates.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 11:50 am

FTRE

Fortrea Holdings reported disappointing Q4 financial results, leading to a decline in its share price. The company also announced plans to divest assets related to its Enabling Services segment.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:47 am

OSG

Overseas Shipholding Gr (OSG) reported a significant increase in Q4 EPS to $0.26, up from $0.11 YoY, despite a slight decrease in sales to $116.02M from $121.76M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:39 am